<DOC>
	<DOCNO>NCT00508833</DOCNO>
	<brief_summary>This study do evaluate effect various adjuvant combination HBsAg model antigen induction immune response , mainly cytotoxic T lymphocyte ( CTL ) healthy volunteer . The study also do evaluate safety reactogenicity various adjuvanted vaccine .</brief_summary>
	<brief_title>Safety Efficacy SmithKline Beecham ( GlaxoSmithKline GSK ) Biologicals ' Candidate Adjuvanted Vaccines ( 287615 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>Healthy volunteer 18 40 year age Written inform consent obtain subject Female nonchildbearing potential Any hepatitis B vaccination . Positive HBV serological marker : antiHBs , antiHBc , and/ HBsAg Pregnancy lactate female Use investigational nonregistered drug vaccine study vaccine within 30 day 7 halflives ( whichever longer ) precede first vaccine administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Adjuvants</keyword>
	<keyword>HBsAg</keyword>
</DOC>